Take Your Trading To The Next Level. Get Started Here!

Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments

January 31, 2024 Comments Off

Biogen said its decision to drop Aduhelm, which had a polarizing approval and launch, was “not related to any safety or efficacy concerns.”